The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2020

Filed:

Apr. 25, 2017
Applicant:

3m Innovative Properties Company, Saint Paul, MN (US);

Inventors:

Naiyong Jing, Saint Paul, MN (US);

Ryan T. Woldt, Minneapolis, MN (US);

Wensheng Xia, Woodbury, MN (US);

Kevin D. Landgrebe, Woodbury, MN (US);

Timothy J. Nies, Stillwater, MN (US);

Bryan A. Baker, Minneapolis, MN (US);

Semra Colak Atan, St. Louis Park, MN (US);

Gary W. Jorgensen, Saint Paul, MN (US);

Giuseppe M. Bommarito, Stillwater, MN (US);

David P. Swanson, Woodbury, MN (US);

George W. Griesgraber, Eagan, MN (US);

Ranjani V. Parthasarathy, Saint Paul, MN (US);

Assignee:

3M Innovative Properties Company, Saint Paul, MN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 2/00 (2006.01); A61L 9/00 (2006.01); B08B 7/00 (2006.01); B08B 9/04 (2006.01); A61L 2/18 (2006.01); A61L 2/28 (2006.01); A01N 35/02 (2006.01); A01N 33/02 (2006.01); C12Q 1/22 (2006.01);
U.S. Cl.
CPC ...
A61L 2/18 (2013.01); A01N 33/02 (2013.01); A01N 35/02 (2013.01); A61L 2/28 (2013.01); C12Q 1/22 (2013.01); A61L 2202/24 (2013.01);
Abstract

A method of disinfecting a medical device comprises three steps. First, a disinfectant is contacted with a process indicator and the medical device. The disinfectant comprises at least one aldehyde. The process indicator contains a synthetic amine-containing compound disposed on a substrate. The synthetic amine-containing compound comprises at least one of primary amino groups or secondary amino groups, and is reactive with the disinfectant to form at least one adduct. The synthetic amine-containing compound and the medical device are in fluid communication through the disinfectant. A predetermined disinfectant exposure criterion exists for contacting the disinfectant with the medical device. Second, the process indicator is spectrally observed and at least one parameter is obtained therefrom that is predictive of the predetermined disinfectant exposure criterion. The third step is determining that the predetermined disinfectant exposure criterion has been achieved.


Find Patent Forward Citations

Loading…